No Data
Because Mina has launched a pilot proteomics project in collaboration with biobanks and biopharmaceutical partners in the United Kingdom.
The research will generate key reference datasets using Illumina Protein Prep solutions. San Diego, California, USA, January 14, 2025 /PR Newswire/ -- The global leader in Gene Sequencing and microarray technology, Illumina (Nasdaq: ILMN), announced a collaboration with deCODE Genetics, Standard BioTools, Tecan, GlaxoSmithKline, Johnson & Johnson, and Novartis to launch a pilot proteomics project analyzing samples from the UK Biobank.
Because Minna is collaborating with NVIDIA to decode biology and promote the development of precision health.
The collaboration between the two parties will combine Genomics sequencing technology and Illumina Connected Software solutions with NVIDIA tools to jointly develop biological foundational models. San Diego, California, January 14, 2025 /PR Newswire/ -- The global leader in Gene Sequencing and chip technology, Illumina (Nasdaq: ILMN), announced a partnership with NVIDIA to advance the development of multi-omics data analysis and interpretation technology platforms, accelerating the progress of clinical research, genomics AI development, and drug discovery. In order to optimize the massive amounts of data involved in multi-omics research.
RBC Capital Keeps Their Buy Rating on Illumina (ILMN)
Futu Morning Report | Major new regulations impact AI Chip stocks! NVIDIA and Oracle strongly oppose; Is there a bet that the yield has peaked? Call Bid in U.S. Treasury ETF surges.
Media: NVIDIA's Blackwell chip rack has encountered issues, leading major customers like Microsoft to reduce some Orders; Trump's advisers have proposed a new tariff idea: use the Emergency Economic Powers Act to increase rates by 2-5% monthly; the new US Treasury Secretary's Hold Positions include the S&P 500, Nasdaq, and Bitcoin.
Illumina Is Maintained at Equal-Weight by Morgan Stanley
Illumina Analyst Ratings